These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 68817)

  • 21. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
    Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoelectron microscopic studies of antibodies in mouse sera directed against mouse mammary tumor virus.
    Miller MF; Dmochowski L; Bowen JM
    Cancer Res; 1977 Jul; 37(7 Pt 1):2086-91. PubMed ID: 193633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of hypoxia-inducible factor 1alpha in human normal, benign, and malignant prostate tissue.
    Du Z; Fujiyama C; Chen Y; Masaki Z
    Chin Med J (Engl); 2003 Dec; 116(12):1936-9. PubMed ID: 14687488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer.
    König JE; Senge T; Allhoff EP; König W
    Prostate; 2004 Feb; 58(2):121-9. PubMed ID: 14716737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Free/total prostate specific antigen ratio (%PSA) to predict probability of prostate cancer].
    Zenimoto M; Kita M; Arai T; Murayama T; Mori M
    Rinsho Byori; 2003 Oct; 51(10):969-73. PubMed ID: 14653195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples.
    Festuccia C; Angelucci A; Gravina GL; Muzi P; Miano R; Vicentini C; Bologna M
    Int J Oncol; 2005 May; 26(5):1353-62. PubMed ID: 15809728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrastructure of human prostatic epithelium. Secretion granules or virus particles?
    Webber MM; Bouldin TR
    Invest Urol; 1977 May; 14(6):482-7. PubMed ID: 192689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
    Tang DG; Li L; Chopra DP; Porter AT
    Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AtT20 pituitary tumour cells contain mouse mammary tumour virus and intracisternal A-type particles in addition to murine leukemia virus.
    Tooze J; Tooze S; Haisma H; Hilgers J
    Eur J Cell Biol; 1985 Nov; 39(1):224-31. PubMed ID: 2417843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of indoleamine 2,3-dioxygenase gene in prostate cancer.
    Feder-Mengus C; Wyler S; Hudolin T; Ruszat R; Bubendorf L; Chiarugi A; Pittelli M; Weber WP; Bachmann A; Gasser TC; Sulser T; Heberer M; Spagnoli GC; Provenzano M
    Eur J Cancer; 2008 Oct; 44(15):2266-75. PubMed ID: 18619832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA tumor virus-like activities in human prostate: possible novel pharmacologic approaches.
    Arya SK; Job L; Horoszewicz JS; Zeigel RF; Carter WA
    Cancer Treat Rep; 1977; 61(2):113-7. PubMed ID: 68816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
    Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human cytomegalovirus and herpes simplex type 2 virus in normal and adenocarcinomatous prostate glands.
    Boldogh I; Baskar JF; Mar EC; Huang ES
    J Natl Cancer Inst; 1983 May; 70(5):819-26. PubMed ID: 6188872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Serum antibody levels of cytomegalovirus, herpes simplex type I and adenovirus in patients with benign or malignant prostatic neoplasms].
    Peker AF; Erkan I; Ozen HA; Ustaçelebi S; Ozdemir T
    Mikrobiyol Bul; 1986 Jul; 20(3):165-75. PubMed ID: 2436029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10.
    Li Z; Habuchi T; Tsuchiya N; Mitsumori K; Wang L; Ohyama C; Sato K; Kamoto T; Ogawa O; Kato T
    Carcinogenesis; 2004 Feb; 25(2):237-40. PubMed ID: 14604900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients.
    Horoszewicz JS; Kawinski E; Murphy GP
    Anticancer Res; 1987; 7(5B):927-35. PubMed ID: 2449118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Search for C-type particles in human neoplasia.
    Szakacs JE; Szakacs MR
    Ann Clin Lab Sci; 1975; 5(1):14-22. PubMed ID: 46142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virus retrieval studies in human neoplasia.
    Dmochowski L; Georgiades J; East JL; Allen PT; Bowen JM
    Bibl Haematol; 1975; (40):431-49. PubMed ID: 51629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunofluorescent evidence of prior herpes simplex virus type-2 infection in prostate carcinoma.
    Haid M; Sharon N
    Urology; 1984 Dec; 24(6):623-5. PubMed ID: 6209848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.